Cargando…
Identification of key genes involved in tumor immune cell infiltration and cetuximab resistance in colorectal cancer
BACKGROUND: The anti-epidermal growth factor receptor (EGFR) antibody introduces adaptable variations to the transcriptome and triggers tumor immune infiltration, resulting in colorectal cancer (CRC) treatment resistance. We intended to identify genes that play essential roles in cetuximab resistanc...
Autores principales: | Liang, Li, Liu, Mengling, Sun, Xun, Yuan, Yitao, Peng, Ke, Rashid, Khalid, Yu, Yiyi, Cui, Yuehong, Chen, Yanjie, Liu, Tianshu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905896/ https://www.ncbi.nlm.nih.gov/pubmed/33632198 http://dx.doi.org/10.1186/s12935-021-01829-8 |
Ejemplares similares
-
Asparaginyl endopeptidase contributes to cetuximab resistance via MEK/ERK signaling in RAS wide-type metastatic colorectal cancer
por: Xu, Xiaojing, et al.
Publicado: (2023) -
Negative correlation between acetyl-CoA acyltransferase 2 and cetuximab resistance in colorectal cancer: Correlation between ACAA2 and cetuximab resistance in CRC
por: Yuan, Yitao, et al.
Publicado: (2023) -
FoxO3a confers cetuximab resistance in RAS wild-type metastatic colorectal cancer through c-Myc
por: Yu, Yiyi, et al.
Publicado: (2016) -
Predictive role of UCA1-containing exosomes in cetuximab-resistant colorectal cancer
por: Yang, Ying-nan, et al.
Publicado: (2018) -
Identification of key serum biomarkers for the diagnosis and metastatic prediction of osteosarcoma by analysis of immune cell infiltration
por: Chen, Zhihao, et al.
Publicado: (2022)